Molecular genetics of schizophrenia: Past, present and future

Journal of Biosciences

Volumn 27, Issue 1 SUPPL. 1, 2002, Pages 35-52

  Prasad, Suman ^a   Semwal, Prachi ^a   Deshpande, Smita ^b   Bhatia, Triptish ^a   Nimgaonkar, V L ^c   Thelma, B K ^a  

^a UNIVERSITY OF DELHI   (India)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Association strategy; Candidate genes sites; Linkage analysis; Neurotransmitters; Schizophrenia

Indexed keywords

DOPAMINE; NEUROTRANSMITTER; SEROTONIN;

GENETICS; MENTAL HEALTH;

CHROMOSOME ANALYSIS; DNA MICROARRAY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; HUMAN; HUMAN GENETICS; INHERITANCE; MOLECULAR GENETICS; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0036209088     PISSN: 02505991     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02703682     Document Type: Review

References (205)

1. Serotonin model of schizophrenia: Emerging role of glutamate mechanisms
2. Lack of linkage or association between schizophrenia and the polymorphic trinucleotide repeat within the KCNN3 gene on chromosome 1q21
3. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease
4. Serotonin2 (5HT2) receptor binding in the frontal cortex of schizophrenic patients
5. Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response
6. A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder
7. DRD2 Ser311/Cys311 polymorphism in schizophrenia
8. Mapping of hKCa3 to chromosome 1q21 and investigation of linkage of CAG repeat polymorphism to schizophrenia
9. Chromosome 13 workshop report
10. A review of central 5-HT receptors and their function
11. 22q11 deletion syndrome: A genetic subtype of schizophrenia
12. 22q11 deletion syndrome in adults with schizophrenia
13. Evidence for anticipation in schizophrenia
14. Seasonality and infectious disease in schizophrenia: The birth hypothesis revisited
15. Epigenetic effects in eukaryotic gene expression
16. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21
17. Construction of a genetic linkage map in man using restriction fragment length polymorphisms (RFLPs)
18. Replication of association between a polymorphic CAG repeat in the hSKCa3 genes and schizophrenia
19. Serotonin transporter gene polymorphism and schizophrenia: An association study
20. No association between the tyrosine hydroxylase microsatellite marker HUMTHO1 and schizophrenia or bipolar I disorder
21. Human dopamine transporter gene not linked to schizophrenia in multigenerational pedigrees
22. Linkage analysis between schizophrenia and index simple-sequence repeat loci for chromosome 21
23. Psychiatric disorder in a familial 15;18 translocation and sublocalization of myelin basic protein of 18q22·3
24. Fine mapping of the human 5-HTR2a gene to chromosome 13q14 and identification of two highly polymorphic linked markers suitable for association studies in psychiatric disorders
25. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees
26. Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: A candidate for schizophrenia and bipolar disorder?
27. Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene
28. Lack of association between 102T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese
29. Systematic mutation analysis of the catechol-O-methyltransferase gene as a candidate gene for schizophrenia
30. Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family based samples
31. Detection of four polymorphic sites in the human D1 receptor gene (DRD1)
32. Chromosme Workshop: Chromosomes 11, 14 and 15
33. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene
34. X-Y linkage and schizophrenia
35. Influenza and schizophrenia
36. Evidence for HLA-linked genes in "juvenile" diabetes mellitus
37. No evidence for linkage between schizophrenia and markers at chromosome 15q13-14
38. Pseudoautosomal region in schizophrenia: Linkage analysis of seven loci by sib-pair and lob score methods
39. No association between schizophrenia and polymorphisms within the genes for Debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter
40. A linkage study of schizophrenia to markers within Xp11 near the MAOB gene
41. Systematic search for major genes in schizophrenia: Methodological issues and results from chromosome 12
42. Molecular cloning and expression of the gene for a human D1 dopamine receptor
43. Schizophrenia and smoking: An epidemiological survey in a state hospital
44. The genetics of schizophrenia: Past, present and future concepts
45. An analysis of lymphocyte subpopulation in schizophrenic patients
46. Herpes simplex virus, cytomegalovirus and Epstein-Barr antibody titres in sera from schizophrenic patients
47. A hindi version of the diagnostic interview for genetic studies
48. Chromosome 12 and 16 workshop
49. An experimental study of the ocular reactions of the photographic records
50. Association study between dopamine D1, D2, D3, and D4 receptor genes and schizophrenia defined by several diagnostic systems
51. Possible role for COMT in psychosis associated with velo-cardiofacial syndrome
52. Schizophrenia and rheumatoid arthritis: A review
53. Systematic screening for mutations in the promoter and the coding region of the 5HT 1A gene
54. Systematic screening for mutations in the human serotonin-2A (5HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia
55. The transmission/diseqilibrium test: History, subdivision, and admixture
56. Genome scan of European-American schizophrenia pedigrees: Results of the NIMH genetics initiative and millennium constortium
57. Juvenile onset diabetes and schizophrenia?
58. Erythrocyte catechol-o-methyltransferase activity in related families with schizophrenia
59. Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees
60. The number of triplet repeats in five brain-expressed loci with CAG repeats is not associated with schizophrenia
61. Increased serum interleukin-2-receptor concentration in schizophrenic and brain damaged subjects
62. Clinical and laboratory evidence of autoimmunity in acute schizophrenia
63. A piece in the puzzle: An ion channel candidate gene for schizophrenia
64. Genome wide scan and schizophrenia in African Americans
65. Chromosomes 19 and 20 report
66. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia
67. HLA and schizophrenia; refutation of reported associations with A9 (A23/A24), DR4 and DQB1*0602
68. A linkage study of schizophrenia with DNA markers from the long arm of chromosome 11
69. Clonage du gene recepteur dopaminergique D3 humain et identification de son chromosome
70. Cloning of the cDNA and gene for a human D2 dopamine receptor
71. A human D1 dopamine receptor gene is located on chromosome 5 at q35-1 and identifies an EcoRI RFLP
72. Single nucleotide polymorphisms as tools in human genetics
73. Meta-analysis for model-free methods
74. Chromosome 21 workshop
75. No association between a polymorphic CAG repeat in the human potassium channel gene hKCa3 and bipolar disorder
76. Exclusion of linkage between the serotonin 2 receptor and schizophrenia in a large Swedish kindred
77. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis
78. No association or linkage between the 5-HT2a/T102C polymorphism and schizophreniain Irish families
79. 102T/C polymorphism of serotonin receptor type 2A gene is not associated with schizophrenia in either Chinese or British populations
80. Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody technique
81. Allelic variation of human serotonin transporter gene expression
82. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia
83. DNA methylation and epigenetic mechanisms
84. Eye-tracking patterns in schizophrenia
85. Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p 20p and 22q in a population-based sampled Finnish family set
86. Serotonin transporter gene and schizophrenia: Evidence for association/linkage disequilibrium in families with affected siblings
87. An association between schizophrenia and a serotonin receptor DNA marker (5HTR2)
88. Borna disease virus infection and schizophrenia: Seroprevalence in schizophrenia patients
89. Analysis of thirteen trinucleotide repeat loci as candidate genes for schizophrenia and bipolar affective disorder
90. Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene
91. Failure to replicate an association between a rare allele of a tyrosine hydroxylase gene microsatellite and schizophrenia
92. Trend for an association between schizophrenia and D3S310, a marker in proximity to the dopamine D3 receptor gene
93. Anticipation in schizophrenia: Biology or bias?
94. Lack of association between the hSKCa3 channel gene CAG polymorphism and schizophrenia
95. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics
96. NIMH genetics initiative millennium schizophrenia consortium: Linkage analysis of African-American pedigrees
97. Multiple receptors for dopamine
98. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish study of high density schizophrenia families
99. Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish pedigree
100. Chromosome 4 workshop
101. Can autoimmune mechanisms account for the genetic predisposition for schizophrenia?
102. Dopamine receptor stimulating autoantibody: A possible cause of schizophrenia
103. 6 serotonin receptor
104. Dopamine D1 receptor gene polymorphism and schizophrenia in Japan
105. No correlation between A(-1438)G polymorphism in 5HT2A receptor gene promoter and the density of frontal cortical 5HT2A receptors in schizophrenia
106. Eye tracking dysfunction and schizophrenia: A critical perspective
107. No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population
108. A TaqI RFLP at the DRD1 locus
109. Screening the dopamine D1 receptor gene in 131 schizophrenics and eight alcoholics
110. Lack of linkage between schizophrenia and markers at the telomeric end of the pseudoautosomal region of the sex chromosome
111. Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia
112. Possible involvement of serotonin receptors in anxiety disorders
113. A balanced 2:18 translocation and familial schizophrenia: Falling short of an association
114. The genetic basis of schizophrenia
115. Exclusion of a schizophrenia susceptibility gene from the chromosome 5q11-13 region: New data and a reanalysis of previous reports
116. Large CAG/CTG repeats are associated with childhood-onset schizophrenia
117. Anticipation: An old idea in new genes
118. Association of manic depressive illness with the TH locus using a microsatellite marker localized in the tyrosine hydroxylase gene
119. Schizophrenia and the dopamine-beta hydroxylase gene: Results of a linkage and association study
120. DQCAR microsatellite polymorphisms in three selected HLA class II-associated diseases
121. An international two-stage genome wide search for schizophrenia susceptibility genes
122. CAG repeat expansions and schizophrenia: Association with disease in females and with early age-at-onset
123. Cellular immunity in schizophrenic patients before and during neuroleptic treatment
124. Chromosome 22q11 deletions. An underrecognized cause of idiopathic learning disability
125. Genetic polymorphism of the 3′ VNTR region of the human dopaminergic function gene DAT1 (Human Dopamine Transporter Gene) in the Mongolian population
126. DRD2 Ser311/Cys311 polymorphism in schizophrenia
127. A study of association between schizophrenia and dopamine D3 receptor gene
128. No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampus
129. A negative association of schizophrenia with an allele of the HLA DQB1 gene among African-Americans
130. Negative association of schizophrenia with HLADQB1*0602: Evidence from a second African-American cohort
131. Further evidence for an association between schizophrenia and the HLADQB1 gene locus
132. Association study of schizophrenia with dopamine D3 receptor gene polymorphisms: Probable effects of family history
133. 5-HT2 receptor gene locus: Association with schizophrenia or treatment response not detected
134. Identification of genetic variation in the human serotonin1Dβ receptor gene
135. Lack of association between schizophrenia and alleles of the dopamine D1, D2, D3 and D4 receptor loci
136. Excess of homozygosity at the dopamine D3 receptor gene in schizophrenia not confirmed
137. Expanded CAG repeats in schizophrenia and bipolar disorder
138. Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia
139. Retroviruses and schizophrenia revisited
140. No evidence for linkage between schizophrenia and eight microsatellite markers on chromosome 19
141. No evidence for linkage or association between the dopamine transporter gene and schizophrenia in a French population
142. Genotypic association between dopamine transporter gene polymorphisms and schizophrenia
143. Dopamine transporter gene markers are not associated with polysubstance abuse
144. Exclusion of close linkage of the dopamine transpoter gene with schizophrenia spectrum disorders
145. The genes for major psychosis: Aberrant sequence or regulation?
146. Schizophrenia: An epigenetic puzzle
147. An association study of schizophrenia among Indian families
148. Schizophrenia: A genome scan targets chromosome 3p and 8p as potential sites of susceptibility genes
149. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives
150. Schizophrenia and the serotonin transporter gene
151. Failure to exclude a possible schizophrenia susceptibility locus on chromosome 13q14·1-q32 in southern African Bantu speaking families
152. Linkage and associated studies of schizophrenia
153. A linkage study of the N-Methyl-D-aspartate receptor subunit gene loci and schizophrenia in southern African-Bantu speaking families
154. Linkage strategies for genetically complex traits. I. Multilocus models
155. Genes with triplet repeats: Candidate mediators of neuropsychiatric disorders
156. Identification of four variants in the tryptophan hydroxylase promoter and association to behaviour
157. Study of the Huntington's disease (HD) gene CAG repeats in schizophrenic patients shows overlap of the normal and HD affected ranges but absence of correlation with schizophrenia
158. Association analysis of 5HT transporter gene in bipolar disorder in the Indian population
159. Association analysis of CAG repeats at KCNN3 locus Indian patients with bipolar disorder and schizophrenia
160. Variation at the MJD locus in the major psychoses
161. Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia
162. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis
163. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis
164. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis
165. Chemical brain anatomy in schizophrenia
166. Family based studies of monoaminergic gene polymorphism among Indians with schizophrenia
167. Lack of association between tryptophan hydroxylase gene and psychotic symptamatology in schizophrenia
168. A genome-scan search for schizophrenia susceptibility genes
169. DRD2 Ser311/Cys311 polymorphism in schizophrenia
170. Localization of a susceptibility locus for schizophrenia on chromosome 5
171. Anticerebral antibodies in functional psychoses
172. 6 receptor gene in schizophrenia
173. New polymorphism for the human serotonin 1D receptor variant (5HTID) beta linked to schizophrenia in five Canadian pedigrees
174. Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree
175. S311C D2DR variant: No association with schizophrenia
176. Immunologic abnormalities in mental illness
177. Dopamine D4 receptor variants in unrelated schizophrenic cases and controls
178. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter
179. Indoleamines and schizophrenia
180. Association within a family of a balanced autosomal translocation with major mental illness
181. Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families
182. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: Evidence for genetic heterogeneity
183. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1
184. An overview of the genetic analysis of complex diseases, with reference to type I diabetes
185. HLA and insulin gene associations with IDDM
186. 14-3-3 Protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia
187. To be or not to be Asp57, that is the question
188. Glutamatergic neurotransmission involves structural and clinical deficits of schizophenia
189. Human dopamine transporter gene (DAT1) maps to chromosome 5p15·3 and displays a VNTR
190. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially dimorphic Taq I RFLPs
191. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
192. No association between schizophrenia and the serotonin receptor 5HTR2a in an Italian population
193. An MspI polymorphism in the human serotonin receptor gene (HTR2): Detection by DGE and RFLP analysis
194. The NOTCH4 locus is associated with susceptibility to schizophrenia
195. Metaanalysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia
196. Association between schizophrenia and T102C polymorphism of the 5-hydroxytrptamine type 2a receptor gene
197. A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs
198. The human small conductance calcium-regulated potassium channel gene (hSKCa3) contains two CAG repeats in exon 1, is on chromosome 1q21·3, and shows a possible association with schizophrenia
199. Genetic association of the HLADRB1 gene locus on chromosome 6p21·3 with schizophrenia
200. Cytogenetic studies in a Y-to-X translocation observed in three members of one family, with evidence of infertility in male carriers
201. Endogenous retroviruses and schizophrenia
202. Study of the possible association of HLA class II, CD4, and CD3 polymorphisms with schizophrenia